Company intelligence / Profile preview

Minerva Surgical

Santa Clara, California, United Statesstocktitan.net ↗

Ownership: Public · UTRS
Employees: ~150
Development stage: Commercial

Overview

Minerva Surgical has developed and commercialized a suite of minimally invasive intrauterine devices to treat abnormal uterine bleeding. Their products are FDA-approved and have demonstrated validated clinical results in endometrial ablation and tissue resection. The company’s solutions are designed as alternatives to hysterectomy, aiming to preserve the uterus while effectively treating AUB.

Therapeutic areas: Women's Health
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

4 assets

Minerva ES

Commercial

Indications: Abnormal Uterine Bleeding

3 more assets in the full pipeline.

Request access →

Financials

Market cap: $888
Total revenue: $12M
Enterprise value: $32.4M

Beyond the preview

Go deeper on Minerva Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Minerva Surgical.

Explore the full profile